FeaturedNews Batavia wins 2022 ViE Award for Best Process Development Washington, April 20, 2022 - Batavia Biosciences was honored this week during the Vaccine Industry…Claire Otjes20 April 2022
News Batavia Biosciences appoints Ron van Eijsden, Ph.D., as Head of Business Development With Ron van Eijsden heading the Sales and Business Development team, Batavia expands its Management…Aaron Ogdahl12 April 2022
News Batavia Biosciences joins the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Woburn, MA, USA, March 22, 2022 -- Batavia Biosciences Inc. announces today that it has…Aaron Ogdahl22 March 2022
News Batavia Biosciences partners with CJ CheilJedang to propel its business expansion Batavia Biosciences is proud to announce that CJ CheilJedang (Seoul, South Korea) has selected the…tristan8 November 2021
News Batavia’s HIP-Vax® selected to propel IAVI’s VSV-vector based Sudan ebolavirus vaccine candidate from bench to clinic Leiden, The Netherlands, October 28, 2021 – Batavia Biosciences is pleased to announce today that…tristan28 October 2021
News Batavia Biosciences is expanding its viral vector process development capacity in Massachusetts Today, Batavia Biosciences announces the expansion of its process development facilities in Woburn, MA, United…tristan31 August 2021
News Batavia successfully uses innovative HIP-Vax to manufacture IAVI’s Lassa fever vaccine candidate for Phase I clinical trials Leiden, The Netherlands, July 14, 2021 – Batavia Biosciences announces today that they have successfully…tristan14 July 2021
News Batavia to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine Leiden, 6 July 2021 – Today, Batavia Biosciences announces their collaboration with RocketVax, a subsidiary…tristan6 July 2021
News Meet our newest team member: Alec We would like to introduce you to our newest team member: kingfisher Alec! Alec is…tristan25 February 2021
News Batavia and KU Leuven join forces to accelerate development of highly promising COVID-19 vaccine candidate Leiden, 3 December 2020 – KU Leuven, a leading research institution and one of the…tristan3 December 2020